Equity
€776,519 ▲ 5.8%
Dr. Dirk Claes paid out €140,000 in dividends. That is 77% of the 2025 profit.
Dr. Dirk Claes
Lifetime
16 annual accounts with figures on one time axispeak €291,108 (2023)
€272,718▼ 3.1%
peak €182,523 (2025)
€182,523▲ 11.2%
peak €776,519 (2025)
€776,519▲ 5.8%
€189,151▼ 3.0%
Board1 name since 2023
1 directorCLAES Dirk Jozef
Owners
Documentsfilings and deeds
28-01-20263 days before the deadline
2025micro format
Dividend €140,000Cash from €157,083 to €293,031
Key points
from the 2025 annual accountsFilings
16 annual accounts since 2010
The last five annual accounts were filed 0 to 51 days before the end of the period.
Position in the sector
€776,519
More equity than 90% of companies in human health. Sector median €124,598 · 20,769 companies.
Checked score
95
Excellent
Financially stronger than 61% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025highest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.33, cash €293,031
Equity €776,519 (80.4% of total assets)
Size: total assets €965,670
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 65% on liquidity, 49% on profitability and 47% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-06-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as Dr. Dirk Claes has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
That fits the bankruptcy probability of Dr. Dirk Claes itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for Dr. Dirk Claes. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.33 (4.97 in 2024), above the usual 1.5. Short-term debt is 19% and cash 30.3% of total assets. 19.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-01-2026, 3 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
3 days early
2024
51 days early
2023
40 days early
2022
on the day
2021
on the day
2020
2 days early
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 14 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 28 January (4 of the last 5 accounts filed within 37 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end10-11-2026 today31-01-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0809417092
Change of role: CLAES Dirk Jozef, from statutory manager to statutory director
“Verzekeringsgeneeskunde; Evaluatie menselijke schade” (deed in Dutch) · Director discharge: CLAES Dirk Jozef · General meeting of 23-05-2023 · Gazette deed
Incorporation
published on 30-01-2009 · Gazette deed
First establishment
Heidestraat 15, Sint-Katelijne-Waver
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Dirk Claes Sint-Katelijne-Waver | €1.0m | €272,718 | 80.4% | - |
| Dr DELVIGNE Muriel Sint-Katelijne-Waver | €0.9m | €240,371 | 96.0% | - |
| DOKTER SVEN VERCAUTEREN Duffel | €1.0m | €273,853 | 89.5% | - |
| DOKTER BART BRYON Zandhoven | €1.0m | €281,171 | 90.0% | - |
| Dr. J. van Dongen Antwerp | €1.0m | €274,255 | 78.0% | - |
| Dokter Heidi Van den Bulck Bonheiden | €0.9m | €286,806 | 87.2% | - |
| Dr. Thomas Botelberge Antwerp | €0.9m | €279,883 | 87.5% | - |
These companies have the same main activity as Dr. Dirk Claes: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €881,000 and €1m, founded between 2008 and 2009.
Official details
Source: KBO- Status
- Active since 28-01-2009Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.191.307.7962860 Sint-Katelijne-Waver, since 28-01-2009
- Financial year end
- 30 June
- Peppol
- Reachable since 03-12-2025
Annual accounts to 30-06-2025
- ≈ €410,000estimated
- €965,670▲ 4.0%
- Filing
- Filed on 28-01-2026, 3 days before the end of the filing period
Insights on Dr. Dirk Claes
Dr. Dirk Claes files the micro format. That format states no turnover. The gross margin rose from €176,014 in 2010 to €272,718 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Dirk Claes
- What is the company number of Dr. Dirk Claes?
- The company number of Dr. Dirk Claes is 0809.417.092. The VAT number is the same number with BE in front: BE 0809.417.092.
- Where is Dr. Dirk Claes based?
- The registered office is at Heidestraat 15, 2860 Sint-Katelijne-Waver.Company details
- What does Dr. Dirk Claes do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Dirk Claes?
- Dr. Dirk Claes is a private limited company (BV).
- When was Dr. Dirk Claes founded?
- Dr. Dirk Claes was founded on 28-01-2009.
- Is Dr. Dirk Claes still active?
- Yes, Dr. Dirk Claes is an active enterprise in the KBO register.
- What is the turnover of Dr. Dirk Claes?
- The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €272,718 and 30 comparable companies (NACE 86220). It probably lies between €370,000 and €570,000.Financials
- Is Dr. Dirk Claes profitable?
- In financial year 2025, Dr. Dirk Claes made a profit of €182,523.
- Where can I find the annual accounts of Dr. Dirk Claes?
- Dr. Dirk Claes filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Dirk Claes due?
- Dr. Dirk Claes must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.